Clinical Trial Update: Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of a GLP-1 receptor agonist for steroid-induced diabetes, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperglycemia
• Steroid-induced Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist therapy (glucagon-like peptide-1 receptor agonist)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Steroid-Induced Diabetes, Steroid-Induced Hyperglycemia | Phase 4 | Status: ENROLLING_BY_INVITATION